The mTOR Signaling Pathway: Key Regulator and Therapeutic Target for Heart Disease

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Cell Signaling

Background:

• Heart disease is a major global cause of death.
• The mammalian target of rapamycin (mTOR) kinase controls vital cellular functions.
• mTOR signaling is implicated in cardiovascular health and disease progression.

Purpose of the Study:

• To review the structure, function, and regulation of the mTOR pathway.
• To explore the molecular mechanisms of mTOR in cardiac diseases.
• To assess the therapeutic potential of mTOR inhibitors for heart disease.

Main Methods:

• Literature review of mTOR signaling in cardiovascular contexts.
• Analysis of molecular pathways linking mTOR to cardiac pathophysiology.
• Evaluation of preclinical and clinical data on mTOR inhibitors.

Main Results:

• mTOR signaling pathways are intricately involved in cardiac growth, metabolism, and survival.
• Dysregulation of mTOR contributes to conditions such as cardiac hypertrophy and heart failure.
• mTOR inhibitors have demonstrated potential in preclinical models of cardiovascular disease.

Conclusions:

• The mTOR signaling pathway is a critical regulator of cardiac function and disease.
• Targeting mTOR offers a promising therapeutic strategy for managing heart disease.
• Further research into mTOR inhibitors could lead to novel cardiovascular treatments.